id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2018-N-1768-0003,FDA,FDA-2018-N-1768,Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal,Notice,Notice of Renewal,2022-07-06T04:00:00Z,2022,7,2022-07-06T04:00:00Z,,2022-07-06T14:08:02Z,2022-14346,0,0,09000064851b25a6